T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTY
1901
Getty Realty Corp
GTY
$2.07B
| $922K | ﹤0.01% |
31,542
+1,866
| +6% | +$52.9K |
|
1902
Ironwood Pharmaceuticals
IRWD
$697M
| $922K | ﹤0.01% |
80,584
+8,477
| +12% | +$83.9K |
|
1903
Cimpress
CMPR
$2.33B
| $912K | ﹤0.01% |
11,391
-8
| -0.1% | -$557 |
|
1904
GlobalFoundries
GFS
$29.7B
| $911K | ﹤0.01% |
15,032
+1,945
| +15% | +$108K |
|
1905
Vericel Corp
VCEL
$2.27B
| $911K | ﹤0.01% |
25,559
+170
| +0.7% | +$5.92K |
|
1906
Sera Prognostics
SERA
$78.7M
| $909K | ﹤0.01% |
+151,933
| New | +$441K |
|
1907
Cushman & Wakefield Ltd
CWK
$3.35B
| $907K | ﹤0.01% |
83,922
+28,104
| +50% | +$234K |
|
1908
Myriad Genetics
MYGN
$297M
| $905K | ﹤0.01% |
47,231
+440
| +0.9% | +$7.61K |
|
|
CIM
1909
Chimera Investment
CIM
$991M
| $902K | ﹤0.01% |
60,216
+1,449
| +2% | +$21.9K |
|
|
IRBT
1910
DELISTED
iRobot
IRBT
| $902K | ﹤0.01% |
23,293
+727
| +3% | +$25.9K |
|
1911
Banc of California
BANC
$3.11B
| $900K | ﹤0.01% |
67,006
+41,345
| +161% | +$511K |
|
1912
Bumble
BMBL
$358M
| $899K | ﹤0.01% |
60,943
+2,599
| +4% | +$36.9K |
|
1913
Utz Brands
UTZ
$1.26B
| $899K | ﹤0.01% |
55,339
+12,759
| +30% | +$168K |
|
1914
German American Bancorp
GABC
$1.93B
| $898K | ﹤0.01% |
27,693
+811
| +3% | +$23.7K |
|
1915
Vanguard Morningstar Growth ETF
VUG
$230B
| $898K | ﹤0.01% |
17,328
-1,266
| -7% | -$61.1K |
|
1916
Triumph Financial Inc
TFIN
$1.87B
| $896K | ﹤0.01% |
11,168
+6,192
| +124% | +$419K |
|
|
RCM
1917
DELISTED
R1 RCM Inc. Common Stock
RCM
| $895K | ﹤0.01% |
84,672
+14,723
| +21% | +$167K |
|
1918
Chefs' Warehouse
CHEF
$4.53B
| $893K | ﹤0.01% |
30,340
+1,389
| +5% | +$33.5K |
|
1919
STAAR Surgical
STAA
$1.28B
| $890K | ﹤0.01% |
28,497
+1,907
| +7% | +$68.5K |
|
1920
Sally Beauty Holdings
SBH
$1.52B
| $888K | ﹤0.01% |
66,808
+9,574
| +17% | +$92.7K |
|
1921
Collegium Pharmaceutical
COLL
$915M
| $885K | ﹤0.01% |
28,747
+766
| +3% | +$19.2K |
|
1922
Ligand Pharmaceuticals
LGND
$5.85B
| $885K | ﹤0.01% |
12,382
+860
| +7% | +$50.8K |
|
|
ACH
1923
Accendra Health
ACH
$79.2M
| $880K | ﹤0.01% |
45,615
+1,862
| +4% | +$33.7K |
|
|
DEA
1924
Easterly Government Properties
DEA
$1.17B
| $879K | ﹤0.01% |
26,160
+1,189
| +5% | +$35.2K |
|
1925
West Bancorporation
WTBA
$507M
| $877K | ﹤0.01% |
41,347
+6,800
| +20% | +$122K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.